This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.
Prognosis and treatment of Reglan-related Tardive Dyskinesia: A Detailed Overview — detailed background and analysis.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: MedlinePlus — Trusted Health Information
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.